Amicus Therapeutics Alternatives & Competitors

12 companies similar to Amicus Therapeutics — Our passion for making a difference unites us.

BioCryst Pharmaceuticals, Inc.

We develop oral small-molecule and protein therapeutics to treat hereditary angioedema (HA...

608 Post-IPO Debt $1.65B

Durham, United States

Biotechnology Health and Wellness

Autifony Therapeutics

Autifony are dedicated to developing new medicines to treat rare genetic CNS disorders

37 Venture round $27.00M

Biotechnology Health and Wellness +1

Arven Pharmaceuticals

Hücreden Bitmiş Ürüne- Biyoteknoloji

Istanbul, Turkey

Biotechnology Pharmaceutical

Pharming Group

Transforming the future for our patients.

809 Debt Financing $16.90M

Leiden, The Netherlands

Biopharma Health Care +2

Track all Amicus Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Blue Turtle Bio Technologies, Inc

1 Convertible Note $100.00K

Biotechnology Health Care +1

Lipidio Pharmaceuticals

Transforming Molecules into the Right Medicines

San Diego, United States

Biopharma Biotechnology +2

Chinook Therapeutics, a Novartis Company

Changing the Course of Kidney Care

120 Post-IPO Equity $276.00M

Seattle, United States

Biotechnology Health Care

Dynacure

Dynacure develops new treatments for orphan disorders, focusing on CNM through Dyn101 prog...

Series C $100.27M

Illkirch-graffenstaden, F...

Biotechnology Health Care +2

Forma Therapeutics

Dedicated to transforming the lives of patients with rare hematologic diseases and cancers...

159 Series D $142.50M

Watertown, United States

Biotechnology Health Care +1

Cerium Pharmaceuticals

Rare people. Rare Medicines.

4 Venture round $13.08M

Biotechnology Health Care +2

MediQuest Therapeutics

Pioneering innovative topical treatments for inflammatory and infectious diseases through...

Venture round $44.78M

Biotechnology Health Care +1

CLOVERNA

RNA targeted drug discovery

Kurashiki, Japan

Biopharma Biotechnology +1

About Amicus Therapeutics

Amicus Therapeutics is a global, patient-dedicated biotechnology company founded in 2002 and headquartered in the United States. The company's slogan, "Our passion for making a difference unites us," reflects its commitment to discovering, developing, and delivering high-quality medicines for people living with rare me...

Taxonomy

Pharmaceuticals, Rare Diseases, Patient-centered, Global Footprint, Innovation, Drug Discovery, Medicine Delivery, Entrepreneurship, Compassion, Mission-driven, Global Headquarters, International Presence, Career Opportunities

Frequently Asked Questions

Companies similar to Amicus Therapeutics include BioCryst Pharmaceuticals, Inc., Autifony Therapeutics, Arven Pharmaceuticals, Pharming Group, Blue Turtle Bio Technologies, Inc. They work in Biotechnology and Health Care and share Amicus Therapeutics's focus on rare diseases, pharmaceuticals and patient-centered.

Bounce Watch lists 12 companies that share Amicus Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Amicus Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Amicus Therapeutics Profile BioCryst Pharmaceuticals, Inc. Alternatives Autifony Therapeutics Alternatives Arven Pharmaceuticals Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Amicus Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 26 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.